Calendar Stallergenes Greer

Equities

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		+0.14%	+29.68%

2023	Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes	CI
2023	Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch	CI

cc37280.xjINgMwfqDpXlmt3aBzJnOgXtAHpry9UTbprG5pppI8.sld71b0t61A9ryUFI0X6_qxtjTC860wkB9Q4c-Iw9OaoX0_KhybuTgH3DA~cbc8735d3c8ec6a0bb988565654e6456

No events available

2019-08-28	Interim 2019 Earnings Release
2019-06-13 08:00 am	Annual General Meeting
2019-06-04 07:00 am	European Academy of Allergy and Clinical Immunology Congress
2019-06-02 05:30 am	European Academy of Allergy and Clinical Immunology Congress
2019-05-13 08:15 am	Shareholders Meeting
2019-04-17 02:00 am	Q1 2019 Sales and Revenue Release
2019-03-21 06:30 am	FY 2018 Earnings Call
2019-03-21 02:00 am	FY 2018 Earnings Release
2019-02-13 01:30 am	FY 2018 Sales and Revenue Release
2018-10-24	Investor Day
2018-08-30 05:30 am	Interim 2018 Earnings Call
2018-08-29 03:22 pm	Interim 2018 Earnings Release
2018-06-07 08:00 am	Annual General Meeting
2018-05-08 10:00 am	Deutsche Bank Health Care Conference
2018-03-22 06:30 am	FY 2017 Earnings Call
2018-03-22 02:00 am	FY 2017 Earnings Release
2017-10-25 05:00 am	Innovation Day
2017-08-31 08:00 am	Interim 2017 Earnings Call
2017-08-31 02:00 am	Interim 2017 Earnings Release
2017-06-08 08:00 am	Annual General Meeting

Fiscal Period	December	2017	2018
Net sales Million EUR	Released Forecast Spread	260 262 -0.65%	277 276 0.3%
EBITDA Million EUR	Released Forecast Spread	21,9 19,1 14.66%	40,9 41,5 -1.44%
EBIT Million EUR	Released Forecast Spread	-5,35 -8,80 39.19%	20,9 18,0 16.31%
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-7,15 -3,90 -83.28%	16,7 15,6 6.85%
Net income Million EUR	Released Forecast Spread	-9,87 -9,05 -9.07%	12,8 13,0 -1.85%
EPS EUR	Released Forecast Spread	-0,50 -0,50 0.57%	0,65 0,75 -12.82%
Announcement Date		22/03/18	21/03/19

2024-04-28	FRONTIER BIOTECHNOLOGIES INC.: Q1 2024 Earnings Release (Projected)
2024-04-28	SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-29	YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
2024-04-29	SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-05-05	HK INNO.N CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-06	KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-06	KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release
2024-05-06	CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release
2024-05-08 04:05 pm	SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-08	SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)

2024-04-25	SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-25	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-25 02:00 am	INDIVIOR PLC: Q1 2024 Earnings Release
2024-04-24	CHANGCHUN BCHT BIOTECHNOLOGY CO.: Q1 2024 Earnings Release (Projected)
2024-04-23	SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-19	BETTA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release
2024-04-19	BETTA PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release